Release – Bitcoin Depot Acquires the Assets of National Bitcoin ATM, Significantly Expanding U.S. Footprint

Research News and Market Data on BTM

October 02, 2025 9:14 AM EDT Download as PDF

Acquisition Adds 527 Kiosks Across 27 States, Enhancing Bitcoin Depot’s Nationwide Reach and Service Availability

ATLANTA, Oct. 02, 2025 (GLOBE NEWSWIRE) — Bitcoin Depot (“Bitcoin Depot” or the “Company”) (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced the acquisition of the assets of Westcliff Technologies, d/b/a National Bitcoin ATM (“National Bitcoin ATM”), a prominent BTM operator across 27 states. The acquisition adds over 500 kiosks to Bitcoin Depot’s network, further solidifying its leadership as North America’s largest Bitcoin ATM operator and accelerates the Company’s mission to provide accessible, secure, and convenient Bitcoin access to communities nationwide.

“Adding National Bitcoin ATM`s kiosks significantly expands our reach and increases our leadership in cash-to-crypto access,” said Brandon Mintz, CEO of Bitcoin Depot. “This is exactly the kind of transaction that plays to our strengths–integrating a sizable network quickly and operating it more efficiently with our scale, compliance program, and customer support. As the industry matures, we believe our ability to bring fragmented operators under the Bitcoin Depot umbrella will continue to set us apart in the market.”

Bitcoin Depot BTMs allow customers to seamlessly convert cash into Bitcoin which customers can use to access the broader digital financial system for payments, transfers, remittances, and investments. The additional kiosks complement Bitcoin Depot’s ongoing efforts to strengthen and expand its national footprint to bring more people into the crypto ecosystem. This acquisition brings Bitcoin Depot’s U.S. market share to roughly 30%.

For existing National Bitcoin ATM customers, there will be no disruption in service. The kiosks will remain operational as Bitcoin Depot works to integrate them into its broader network, with the same reliable functionality and the added benefits of Bitcoin Depot’s industry-leading customer support, robust compliance program, and continuous investment in technology and services.

“We are excited to be acquired by the leading operator in the Bitcoin ATM industry” said Luke Hewko. “It has become more difficult to compete in this space as time has gone on due to the resources and expertise needed to operate successfully and we believe Bitcoin Depot is best positioned to succeed in the current environment.”.”

This acquisition marks the latest in a series of momentum-driving announcements for Bitcoin Depot in 2025, including strategic retail partnerships, asset acquisitionsmultiple executive appointments, and a series of BTC treasury updates.

This acquisition had no material impact on the Company’s recently reported third quarter preliminary results.

For more information, visit www.bitcoindepot.com.

About Bitcoin Depot 
Bitcoin Depot Inc. (Nasdaq: BTM) was founded in 2016 with the mission to connect those who prefer to use cash to the broader, digital financial system. Bitcoin Depot provides its users with simple, efficient and intuitive means of converting cash into Bitcoin, which users can deploy in the payments, spending and investing space. Users can convert cash to bitcoin at Bitcoin Depot kiosks in 47 states and at thousands of name-brand retail locations in 31 states through its BDCheckout product. The Company has the largest market share in North America with over 8,800 kiosk locations as of June 2025. Learn more at www.bitcoindepot.com.

About National Bitcoin ATM
For more than a decade, National Bitcoin ATM has provided customers across the United States with instant access to Bitcoin through its network of kiosks. The company’s mission has been to create a reliable on-ramp and trusted touchpoint to the world’s most equitable financial network. National Bitcoin ATM believes that direct, self-custodial access to Bitcoin is a fundamental right and an essential step toward true financial self-sovereignty.

Cautionary Note Regarding Forward-Looking Statements
This press release and any oral statements made in connection herewith include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. Forward-looking statements are any statements other than statements of historical fact, and include, but are not limited to, statements regarding the expectations of plans, business strategies, objectives and growth and anticipated financial and operational performance, including our growth strategy and ability to increase deployment of our products and services, the anticipated effects of the Amendment, and the closing of the Preferred Sale. These forward-looking statements are based on management’s current beliefs, based on currently available information, as to the outcome and timing of future events. Forward-looking statements are often identified by words such as “anticipate,” “appears,” “approximately,” “believe,” “continue,” “could,” “designed,” “effect,” “estimate,” “evaluate,” “expect,” “forecast,” “goal,” “initiative,” “intend,” “may,” “objective,” “outlook,” “plan,” “potential,” “priorities,” “project,” “pursue,” “seek,” “should,” “target,” “when,” “will,” “would,” or the negative of any of those words or similar expressions that predict or indicate future events or trends or that are not statements of historical matters, although not all forward-looking statements contain such identifying words. In making these statements, we rely upon assumptions and analysis based on our experience and perception of historical trends, current conditions, and expected future developments, as well as other factors we consider appropriate under the circumstances. We believe these judgments are reasonable, but these statements are not guarantees of any future events or financial results. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond our control.

These forward-looking statements are subject to a number of risks and uncertainties, including changes in domestic and foreign business, market, financial, political and legal conditions; failure to realize the anticipated benefits of the business combination; future global, regional or local economic and market conditions; the development, effects and enforcement of laws and regulations; our ability to manage future growth; our ability to develop new products and services, bring them to market in a timely manner and make enhancements to our platform; the effects of competition on our future business; our ability to issue equity or equity-linked securities; the outcome of any potential litigation, government and regulatory proceedings, investigations and inquiries; and those factors described or referenced in filings with the Securities and Exchange Commission. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that we do not presently know or that we currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect our expectations, plans or forecasts of future events and views as of the date of this press release. We anticipate that subsequent events and developments will cause our assessments to change.

We caution readers not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other factors that affect the subject of these statements, except where we are expressly required to do so by law. All written and oral forward-looking statements attributable to us are expressly qualified in their entirety by this cautionary statement.

Contacts: 

Investors  
Cody Slach
Gateway Group, Inc.  
949-574-3860  
BTM@gateway-grp.com 

Media  
Brenlyn Motlagh, Ryan Deloney  
Gateway Group, Inc. 
949-574-3860  
BTM@gateway-grp.com 

Primary Logo

Source: Bitcoin Depot Inc.

Released October 2, 2025

Release – CoreCivic Announces 2025 Third Quarter Earnings Release and Conference Call Dates

Research News and Market Data on CXW

October 2, 2025

PDF Version

BRENTWOOD, Tenn., Oct. 02, 2025 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (“CoreCivic”) announced today that it will release its 2025 third quarter financial results after the market closes on Wednesday, November 5, 2025. A live broadcast of CoreCivic’s conference call will begin at 1:30 p.m. central time (2:30 p.m. eastern time) on Thursday, November 6, 2025.

To participate via telephone and join the call live, please register in advance. Upon registration at https://register-conf.media-server.com/register/BIa303aaae094f4f2fa02657400a84f3c6, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique passcode.

Participants may access the audio-only webcast of the conference call from the Company’s website at www.corecivic.com under the “Events & Presentations” section of the “Investors” page. A replay of the webcast will be available for seven days.

About CoreCivic
CoreCivic is a diversified, government-solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways. We provide a broad range of solutions to government partners that serve the public good through high-quality corrections and detention management, a network of residential and non-residential alternatives to incarceration to help address America’s recidivism crisis, and government real estate solutions. We are the nation’s largest owner of partnership correctional, detention and residential reentry facilities, and one of the largest operators of such facilities in the United States. We have been a flexible and dependable partner for government for more than 40 years. Our employees are driven by a deep sense of service, high standards of professionalism and a responsibility to help government better the public good. Learn more at www.corecivic.com.

Contact:Investors: Jeb Bachmann – Managing Director, Investor Relations – (615) 263-3024
Media: Steve Owen – Vice President, Communications – (615) 263-3107

Release – Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference

Research News and Market Data on COCP

October 02, 2025

 Download as PDF

BOTHELL, Wash., Oct. 02, 2025 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company overview at the Noble Capital Markets Emerging Growth Virtual Equity Conference on Thursday, October 9, 2025 at 12:00 pm Eastern time (9:00 a.m. Pacific time). The formal presentation will be followed by a hosted question-and-answer session with questions welcomed from the live virtual audience.

Those interested in viewing the live Cocrystal presentation can register for the event here. A video webcast of the presentation will be available within 48 hours following the event on the Company’s website and archived for 90 days.

Mr. Martin will be available throughout the conference for virtual one-on-one meetings with registered, qualified investors. Meetings can be scheduled by contacting Giorgia Pigato here at Noble Capital Markets.

About Noble Capital Markets, Inc. 
Noble Capital Markets is a research-driven investment bank that has supported small and microcap companies since 1984. As a FINRA and SEC licensed broker dealer, Noble provides institutional-quality equity research, merchant and investment banking, and order execution services. In 2018, Noble launched Channelchek—an investor community dedicated exclusively to public small and micro-cap companies and their industries. Channelchek is the first service to offer investors free institutional-quality research without a subscription.

About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company that addresses significant unmet needs by developing innovative antiviral treatments for challenging diseases including influenza, viral gastroenteritis, COVID, and hepatitis. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs.

Contact:
Alliance Advisors IR
Jody Cain
310-691-7100
jcain@allianceadvisors.com

# # #

Primary Logo

Source: Cocrystal Pharma, Inc.

Released October 2, 2025

Release – Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium

Research News and Market Data on GLSI

 Download as PDFOctober 02, 2025 6:00am EDT

STAFFORD, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the expansion of FLAMINGO-01 clinical trial to Belgium.

The Company’s application to European regulators has been formally approved, adding Belgium as an approved country in FLAMINGO-01 in addition to Spain, France, Germany, Italy, Poland, Romania, Ireland, Portugal, and the US.

According to the latest data collected by the European Cancer Information System (click here), a total of 11,366 new cases of breast cancer were diagnosed in Belgium in 2022, which is the most common cancer diagnosed in women, representing approximately 33% of all cancers in women. Breast cancer is the leading cause of death from cancer in women in Belgium with 2,324 deaths in 2022.

The Company is collaborating with Patrick Neven, MD, PhD, at UZ Leuven, who will be serving as the national principal investigator in Belgium for FLAMINGO-01. Dr Neven is Full Professor at the Department of Gynecological Oncology, University Hospitals Leuven, and is a staff member of the Multidisciplinary Breast Centre. His research focuses on breast oncology, particularly endocrine therapy and quality of life. He has served as principal investigator in multiple clinical trials, published over 300 peer-reviewed papers, and lectured widely at international meetings. He is president of the Belgian Society of Senology, active in several scientific societies, and has mentored numerous doctors and PhD students in breast cancer care.

CEO Snehal Patel commented, “We thank our steering committee for introducing us to Dr. Neven and look forward to working with him and his colleagues. We are planning start-up activities in Leuven in the coming month. Leuven is centrally located in Belgium and is an ideal location to cover large parts of the country, including Brussels and Antwerp.”

About FLAMINGO-01 and GLSI-100

FLAMINGO-01 (NCT05232916) is a Phase III clinical trial designed to evaluate the safety and efficacy of GLSI-100 (GP2 + GM-CSF) in HER2 positive breast cancer patients who had residual disease or high-risk pathologic complete response at surgery and who have completed both neoadjuvant and postoperative adjuvant trastuzumab based treatment. The trial is led by Baylor College of Medicine and currently includes US and European clinical sites from university-based hospitals and academic and cooperative networks with plans to open up to 150 sites globally. In the double-blinded arms of the Phase III trial, approximately 500 HLA-A*02 patients will be randomized to GLSI-100 or placebo, and up to 250 patients of other HLA types will be treated with GLSI-100 in a third arm. The trial has been designed to detect a hazard ratio of 0.3 in invasive breast cancer-free survival, where 28 events will be required. An interim analysis for superiority and futility will be conducted when at least half of those events, 14, have occurred. This sample size provides 80% power if the annual rate of events in placebo-treated subjects is 2.4% or greater.

For more information on FLAMINGO-01, please visit the Company’s website here and clinicaltrials.gov here. Contact information and an interactive map of the majority of participating clinical sites can be viewed under the “Contacts and Locations” section. Please note that the interactive map is not viewable on mobile screens. Related questions and participation interest can be emailed to: flamingo-01@greenwichlifesciences.com

About Breast Cancer and HER2/neu Positivity

One in eight U.S. women will develop invasive breast cancer over her lifetime, with approximately 300,000 new breast cancer patients and 4 million breast cancer survivors. HER2 (human epidermal growth factor receptor 2) protein is a cell surface receptor protein that is expressed in a variety of common cancers, including in 75% of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels.

About Greenwich LifeSciences, Inc.

Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2 protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75% of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. Greenwich LifeSciences has commenced a Phase III clinical trial, FLAMINGO-01. For more information on Greenwich LifeSciences, please visit the Company’s website at www.greenwichlifesciences.com and follow the Company’s Twitter at https://twitter.com/GreenwichLS.

Forward-Looking Statement Disclaimer

Statements in this press release contain “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Greenwich LifeSciences Inc.’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including statements regarding the intended use of net proceeds from the public offering; consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section entitled “Risk Factors” in Greenwich LifeSciences’ Annual Report on the most recent Form 10-K for the year ended December 31, 2024, and other periodic reports filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Greenwich LifeSciences, Inc. undertakes no duty to update such information except as required under applicable law.

Company Contact
Snehal Patel
Investor Relations
Office: (832) 819-3232
Email: info@greenwichlifesciences.com

Investor & Public Relations Contact for Greenwich LifeSciences
Dave Gentry
RedChip Companies Inc.
Office: 1-800-RED CHIP (733 2447)
Email: dave@redchip.com

Primary Logo

Source: Greenwich LifeSciences, Inc.

Released October 2, 2025

Release – FreightCar America, Inc. to Attend Noble Virtual Equity Conference

Research News and Market Data on RAIL

10/01/2025

CHICAGO, Oct. 01, 2025 (GLOBE NEWSWIRE) — FreightCar America, Inc. (NASDAQ: RAIL) (“FreightCar America” or the “Company”), a diversified manufacturer and supplier of railroad freight cars, railcar parts and components, today announced that Nick Randall, Chief Executive Officer, and Michael Riordan, Chief Financial Officer, will participate in one-on-one meetings with investors at the Noble Emerging Growth Virtual Equity Conference, taking place on October 8, 2025.

For additional information or to request a meeting, please contact the Company’s Investor Relations team at RAILIR@riveron.com.

About FreightCar America

FreightCar America, headquartered in Chicago, Illinois, is a leading designer, producer and supplier of railroad freight cars, railcar parts and components. We also specialize in railcar repairs, complete railcar rebody services and railcar conversions that repurpose idled rail assets back into revenue service. Since 1901, our customers have trusted us to build quality railcars that are critical to economic growth and instrumental to the North American supply chain. To learn more about FreightCar America, visit www.freightcaramerica.com.

Investor Contact: RAILIR@riveron.com

Release – NN, Inc. Appoints Gregg Cottage as Chief Information Officer and CISO

Research News and Market Data on NNBR

PDF Version

CHARLOTTE, N.C., Oct. 01, 2025 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, has announced the promotion of Gregg Cottage to serve as its new Chief Information Officer and Chief Information Security Officer. In this position, Mr. Cottage leads the Company’s information technology function, including its enterprise information security strategy. Mr. Cottage will report to Chris Bohnert, Senior Vice President and Chief Financial Officer.

Chris Bohnert, Senior Vice President and Chief Financial Officer of NN, commented, “We are pleased to announce Gregg’s promotion, which will help sharpen NN’s focus on the policies and practices designed to safeguard the Company’s digital assets. Gregg has been a critical member of NN’s information technology team for over ten years, and his experience along with his native knowledge and understanding of the Company’s structure and systems will serve as an important factor in the strengthening of our IT as well as our data security strategies. Gregg has been the primary leader of the IT organization since 2023, and in this new role he will be responsible for leading the next phase of NN’s technology transformation and cybersecurity oversight.”

Mr. Cottage commented, “I am excited to put my experience to work, further strengthening NN’s alignment of enterprise IT with business goals. NN’s brand is synonymous with continued innovation. The combination of differentiated capabilities and process technologies, and our enhanced focus on deploying technology and leveraging data-driven intelligence will enable NN to deliver real, valuable solutions for customers and partners. I look forward to working with the team in this new role to drive continued innovation, expand our impact with customers, and help unlock further opportunities as our business and markets continue to evolve.”

Mr. Cottage has over 30 years of IT experience. Prior to joining NN in 2014, he served in progressive IT roles for multiple Fortune 500 companies and their subsidiaries. His roles at NN included serving as Global IT Infrastructure Manager and Global Director, Information Technology before being promoted to his current position. Mr. Cottage holds a Bachelor of Science in Business Administration and has earned his Chief Information Security Officer (CISO) certification.

About NN, Inc.
NN, Inc., a global diversified industrial company, combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Charlotte, North Carolina, NN has facilities in North America, Europe, South America, and Asia. For more information about the company and its products, please visit www.nninc.com.

This press release contains express and implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “growth,” “guidance,” “intend,” “may,” “will,” “possible,” “potential,” “predict,” “project”, “trajectory” or other similar words, phrases or expressions. Forward-looking statements involve a number of risks and uncertainties that are outside of management’s control and that may cause actual results to be materially different from such statements. Such factors include, among others, general economic conditions and economic conditions in the industrial sector; material changes in the costs and availability of raw materials; the level of our indebtedness; our ability to secure, maintain or enforce patents or other appropriate protections for our intellectual property; and cyber liability or potential liability for breaches of our or our service providers’ information technology systems or business operations disruptions. The foregoing factors should not be construed as exhaustive and should be read in conjunction with the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Company’s filings made with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.

Investor Relations:
Joe Caminiti or Stephen Poe,
InvestorsNNBR@alpha-ir.com
312-445-2870

Primary Logo

Source: NN, Inc.

V2X (VVX) – Some More Awards


Thursday, October 02, 2025

V2X builds innovative solutions that integrate physical and digital environments by aligning people, actions, and technology. V2X is embedded in all elements of a critical mission’s lifecycle to enhance readiness, optimize resource management, and boost security. The company provides innovation spanning national security, defense, civilian, and international markets. With a global team of approximately 16,000 professionals, V2X enables mission success by injecting AI and machine learning capabilities to meet today’s toughest challenges across all operational domains.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Awards. V2X has been the recipient of new awards, including one focused on extending the life-cycle of existing platforms and another driving connectivity and communications. In total, the three new awards total over $580 million of contract value, assuming all funds are spent. We view the recent wins as further confirmation of V2X’s ability to provide full mission lifecycle solutions.

Center Display Units. V2X’s Vertex Modernization and Sustainment unit was awarded by the Air Force a five-year ID/IQ contract with a single five-year option (10 years total) with a contract ceiling of $425 million for center display units (CDU), according to the Department of War’s daily contract awards. V2X will supply the Air Force with the following hardware during this period: CDU full kits, CDU line replaceable units, CDU shop replaceable units, and various other support hardware as required.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

CoreCivic, Inc. (CXW) – An Award for Diamondback


Thursday, October 02, 2025

CoreCivic is a diversified, government-solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways. We provide a broad range of solutions to government partners that serve the public good through high-quality corrections and detention management, a network of residential and non-residential alternatives to incarceration to help address America’s recidivism crisis, and government real estate solutions. We are the nation’s largest owner of partnership correctional, detention and residential reentry facilities, and believe we are the largest private owner of real estate used by government agencies in the United States. We have been a flexible and dependable partner for government for nearly 40 years. Our employees are driven by a deep sense of service, high standards of professionalism and a responsibility to help government better the public good. Learn more at www.corecivic.com.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Diamondback. Yesterday, CoreCivic announced it was awarded a new contract under an Intergovernmental Services Agreement between the Oklahoma Department of Corrections and U.S. Immigration and Customs Enforcement (“ICE”) to resume operations at the Company’s 2,160-bed Diamondback Correctional Facility, a facility that has been idle since 2010.

Details. The new contract commenced on September 30, 2025, for a term of five years and may be extended through bilateral modification. The agreement provides for a fixed monthly payment plus an incremental per diem payment based on detainee populations. Total annual revenue once the facility is fully activated is expected to be approximately $100 million. The facility should begin receiving detainees in the first quarter of 2026, with the full ramp estimated to be complete in the second quarter of 2026.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Seanergy Maritime (SHIP) – Strategic Vessel Sale and Improving Capesize Fundamentals


Thursday, October 02, 2025

Seanergy Maritime Holdings Corp. is a prominent pure-play Capesize shipping company listed in the U.S. capital markets. Seanergy provides marine dry bulk transportation services through a modern fleet of Capesize vessels. The Company’s operating fleet consists of 18 vessels (1 Newcastlemax and 17 Capesize) with an average age of approximately 13.4 years and an aggregate cargo carrying capacity of approximately 3,236,212 dwt. Upon completion of the delivery of the previously announced Capesize vessel acquisition, the Company’s operating fleet will consist of 19 vessels (1 Newcastlemax and 18 Capesize) with an aggregate cargo carrying capacity of approximately 3,417,608 dwt. The Company is incorporated in the Marshall Islands and has executive offices in Glyfada, Greece. The Company’s common shares trade on the Nasdaq Capital Market under the symbol “SHIP”.

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Sale of M/V Geniuship. Seanergy announced the sale of the M/V Geniuship, a 170,057 dwt Capesize vessel, for approximately $21.6 million, generating net cash proceeds of $12.0 million and a profit of about $2.5 million. The sale was timed to take advantage of improved vessel valuations while avoiding the costs of the vessel’s scheduled dry-docking. The transaction enhances liquidity, improves near-term earnings, and aligns with the company’s ongoing fleet renewal strategy.

Capesize market gains momentum. The Capesize market has strengthened in recent months, supported by iron ore and bauxite projects in the Atlantic basin and West Africa, while volatility due to tariffs has moderated. The orderbook remains limited, with shipyard slots not available until 2029. Rising vessel values, together with higher construction costs, have further restricted orders. Overall, we expect market conditions to remain favorable, with 2026 showing improvement over 2025.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Century Lithium Corp. (CYDVF) – Progress on the Permitting Front


Thursday, October 02, 2025

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Moving through the permitting process. Century has completed all required environmental baseline studies to begin Angel Island’s National Environmental Policy Act (NEPA) permitting process, which is expected to take up to two years before reaching a record of decision. The studies will be used by the Bureau of Land Management (BLM) to support the company’s upcoming Plan of Operations submission and subsequent NEPA analysis. 

FAST-41 designation. In August 2025, Angel Island was formally designated as a FAST-41 Transparency project under a federal initiative designed to improve the transparency, coordination, and timeliness of the federal environmental review and permitting process. The designation reflects Angel Island’s strategic importance in supporting the U.S. critical minerals supply chain. We think the Angel Island project is well-positioned for a timely progression through the permitting process.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Rate Cuts, Dry Powder, and the Coming Small-Cap Rally

The Federal Reserve’s latest signal toward additional rate cuts has broad implications for equity markets, but small-cap stocks stand to benefit most prominently. With an estimated $7 trillion in cash and cash-equivalents—often referred to as “dry powder”—sitting on the sidelines, investors are preparing to put capital to work. Much of this capital is housed within private equity funds, institutional investors, and large asset managers, which are all seeking stronger returns as yields on cash and Treasuries decline in a falling-rate environment.

When interest rates fall, sitting on cash becomes less attractive. Investors, pressed to generate higher ROI, begin reallocating money into equities, private deals, and higher-growth opportunities. For small-cap companies, this creates a powerful tailwind. Not only do they benefit from increased investor flows, but they also operate with greater sensitivity to financing conditions. Lower borrowing costs can dramatically improve the profitability outlook for smaller firms, which often rely more heavily on debt and capital markets to fund growth compared to large caps.

M&A Activity and Its Ripple Effects

A large portion of sidelined capital resides within private equity funds, which thrive in environments where acquisition financing is cheaper. Rate cuts reduce the cost of leverage, making buyouts more attractive. The $7 trillion pool of global dry powder is a firehose of liquidity ready to be deployed into merger-and-acquisition deals.

This matters for small caps because acquisition premiums drive valuations higher across the board. As private equity firms, corporations, and even larger small-cap peers target acquisitions, multiples expand—not just for the companies being acquired, but for entire industries as investors speculate on who might be next. This “M&A halo effect” has historically been a significant driver of outperformance in the small-cap space.

Why the Russell 2000 Benefits Disproportionately

The Russell 2000, the most widely watched U.S. small-cap index, tends to be more cyclical and more domestic-focused than large-cap benchmarks. Rate-sensitive sectors such as financials, industrials, and consumer discretionary make up a larger share of its composition. This means the Russell 2000 is positioned to benefit more directly from looser monetary policy than the mega-cap dominated S&P 500 or Nasdaq.

Moreover, small-cap valuations remain historically discounted relative to large caps. The valuation gap, widened after years of tech-driven outperformance at the top end of the market, could narrow sharply as investors re-risk portfolios in search of higher growth potential. History shows that during periods of monetary easing, small caps have often outperformed, fueled by capital inflows, improved earnings prospects, and heightened M&A activity.

The Bottom Line

The confluence of Federal Reserve rate cuts, a massive capital overhang waiting to be deployed, and the natural sensitivity of small-cap companies to interest rate changes sets the stage for a potential rally in the Russell 2000 and broader small-cap landscape. Lower yields make cash less productive, driving investors toward equities. Private equity firms flush with capital will likely target acquisitions, boosting market-wide valuations. And small-cap companies, historically more nimble and growth-oriented, stand to capture the bulk of these benefits.

For investors focused on the small-cap arena, the coming months may present an exceptional entry point. The combination of monetary easing and $7 trillion in sidelined capital seeking higher returns could ignite the small-cap rally that many have been waiting for.

Mortgage Rates Rise Again for Second Straight Week

Mortgage rates have risen slightly for the second consecutive week, with the average 30-year fixed mortgage rate increasing from 6.30% to 6.34% as of early October 2025, according to Freddie Mac data. Despite this uptick, rates remain near the lowest levels seen throughout the year. This rise has led to a noticeable decline in refinancing demand, with refinancing applications dropping by about 21% week over week. However, mortgage applications for home purchases have only declined slightly, showing resilience amid economic uncertainty.

The current mortgage environment is shaped by the Federal Reserve’s recent benchmark interest rate cuts in September 2025, which initially brought optimism for lower borrowing costs. However, investor uncertainty regarding the pace and extent of future rate cuts has kept mortgage rates relatively stable with small fluctuations. Compounded by a government shutdown that delayed key economic data releases, such as the monthly nonfarm payroll report, this has created uncertainty that influences market movements, including mortgage rates.

For small-cap investors, these movements in mortgage rates have important implications. Small-cap stocks are often more sensitive to changes in interest rates because smaller companies tend to carry more floating-rate debt than large-cap firms. Rising rates can increase borrowing costs and pressure profit margins for these companies. Conversely, when rates decline, small caps tend to benefit more significantly due to reduced interest expenses. The recent pause and slight increase in mortgage and borrowing rates may temper the short-term enthusiasm for small caps, but the underlying expectation remains that if the Federal Reserve follows through with further rate cuts later in 2025, small-cap stocks could see renewed gains.

The housing market itself remains challenged by affordability constraints driven by elevated mortgage rates, which have kept many potential buyers priced out. Homeowners with locked-in lower mortgage rates are less incentivized to sell, limiting inventory and putting upward pressure on home prices. This “rate-lock effect” contributes to a cautious but steady housing market with lower transaction volumes. For investors, this means companies involved in new home construction and renovation may represent areas of opportunity, as builders shift focus to new construction to meet demand.

Refinancing demand is a critical signal for the housing market and consumer financial health. The recent 21% drop in refinancing applications after a brief wave earlier in the fall reflects borrowers’ hesitation as rates climbed even slightly. For homeowners who locked in loans at rates above 7.5% in previous years, current rates near 6.3-6.5% may still present refinancing opportunities, though the window to act is becoming narrower. Careful evaluation of refinancing costs versus potential savings is recommended.

In summary, mortgage rates rising modestly for the second week in a row in October 2025 highlights a complex market environment. For small-cap investors, this signals temporary caution as borrowing costs rise slightly, but opportunities may arise if and when the Federal Reserve eases rates further. Housing market dynamics also suggest selective chances in homebuilders and related sectors, fueled by ongoing affordability issues and shifting buyer behavior. Monitoring economic data and Fed policy developments will be key to understanding how mortgage rates, refinancing activity, and small-cap stocks will evolve in the coming months

Release – The Oncology Institute to Participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference

Research News and Market Data on TOI

Oct 01, 2025

PDF Version

CERRITOS, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) — The Oncology Institute (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that  Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference, on October 8, 2025, including a presentation at 11:00am ET.

Interested parties can access a webcast of the presentation by registering at the link listed on the Investor Relations section of the Company’s websites at https://investors.theoncologyinstitute.com/.

About The Oncology Institute (www.theoncologyinstitute.com):

Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.

Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com

Investors
ICR Healthcare
TOI@icrhealthcare.com